Fabriekslevering Lipide-Lowering API Fenofibrate Poeder

opslag
bewaar een koele, droge plaats
bron
natuurlijk
testmethode
hplc
service
welkom om ons te bezoeken
psa
52.60000
markt
wereldwijd
houdbaarheid
2 jaar
mw
360.83100
mf
C20h21clo4
cas-nr
49562-28-9
uiterlijk
wit kristallijn poeder
Transportpakket
Foil Bag
Specificatie
99%
Handelsmerk
Xi′an Frazer Biotech Co., Ltd.
Oorsprong
China
Productiecapaciteit
2000kg/Month
Referentieprijs
$ 107.10 - 128.70

Beschrijving

Factory Supply Lipid-Lowering API Fenofibrate Powder
Factory Supply Lipid-Lowering API Fenofibrate Powder
 

 

Product Description

 Fenofibrate is a drug of the fibrate class. It is mainly used to reduce cholesterol levels in patients at risk of cardiovascular disease. Like other fibrates,it reduces both lowdensity lipoprotein (LDL) and very low density lipoprotein (VLDL) levels,as well as increasing highdensity lipoprotein (HDL) levels and reducing triglycerides level. It is used alone or along with statins in the treatment of hypercholesterolemia and hypertriglyceridemia.

Detailed Photos
Factory Supply Lipid-Lowering API Fenofibrate Powder
Factory Supply Lipid-Lowering API Fenofibrate Powder

 

COA

Factory Supply Lipid-Lowering API Fenofibrate Powder

Function

1. Fenofibrate has significant clinical efficacy in the treatment of lipid abnormalities in diabetic patients.

2. Fenofibrate has the effect of regulating blood lipid.

3. Fenofibrate has anti-inflammatory and lowers fibrinogen levels.

4. Fenofibrate has preventive neuroprotective effects.
 

Application

Fenofibrate is mainly used for primary hypercholesterolemia or mixed dyslipidemia. Fenofibrate appears to decrease the risk of cardiovascular disease and possibly diabetic retinopathy in those with diabetes mellitus, and firstly indicated for the reduction in the progression of diabetic retinopathy in patients with type 2 diabetes and existing diabetic retinopathy in Australia. It also appears to be helpful in decreasing amputations of the lower legs in this same group of people. Fenofibrate also has an off-label use as an added therapy of high blood uric acid levels in people who have gout.

Related Products

 

Factory Supply Lipid-Lowering API Fenofibrate Powder

Factory Supply Lipid-Lowering API Fenofibrate Powder

Factory Supply Lipid-Lowering API Fenofibrate Powder Factory Supply Lipid-Lowering API Fenofibrate Powder Factory Supply Lipid-Lowering API Fenofibrate Powder

 
 
 


 

 

 

GOUV.NE, 2023